Immunic, Inc. Director Duane Nash Resigns; Board Reduced

What Happened Immunic, Inc. (IMUX) announced in an 8-K filed September 11, 2026 that Dr. Duane Nash resigned from the Company’s Board of Directors effective September 10, 2026. The filing states Dr. Nash’s resignation was not the result of any disagreement with the Company regarding its operations, policies, or practices. The Board resolved to reduce its size from ten members to nine in connection with the resignation.

Key Details

• Resigning director: Dr. Duane Nash.
• Resignation effective date: September 10, 2026; 8-K filed September 11, 2026.
• Board size reduced: from 10 members to 9 members by Board resolution.
• Filing also includes Exhibit 104 (Inline XBRL cover page).

Why It Matters A board member departure can affect board dynamics and oversight, though this filing specifies there was no disagreement with company management or policies. For investors, the immediate impact is procedural—the Board size was reduced rather than immediately filled—so watch for future announcements about any new director appointments or changes to committee assignments that could affect governance.